260 related articles for article (PubMed ID: 18613925)
1. Prolactin receptor expression in gynaecomastia and male breast carcinoma.
Ferreira M; Mesquita M; Quaresma M; André S
Histopathology; 2008 Jul; 53(1):56-61. PubMed ID: 18613925
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C) in female and male breast carcinoma.
Serra C; Vizoso F; Lamelas ML; Rodríguez JC; González LO; Merino AM; Baltasar A; Pérez-Vázquez MT; Medrano J
Int J Surg Investig; 2000; 2(3):183-92. PubMed ID: 12678518
[TBL] [Abstract][Full Text] [Related]
3. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
Kwiatkowska E; Teresiak M; Filas V; Karczewska A; Breborowicz D; Mackiewicz A
Clin Cancer Res; 2003 Oct; 9(12):4452-9. PubMed ID: 14555518
[TBL] [Abstract][Full Text] [Related]
4. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
Sharif MA; Mamoon N; Mushtaq S; Khadim MT
J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
[TBL] [Abstract][Full Text] [Related]
5. COX-2 expression does not correlate with microvessel density in breast cancer.
Thorat MA; Mehrotra S; Morimiya A; Badve S
Pathobiology; 2009; 76(1):39-44. PubMed ID: 19188749
[TBL] [Abstract][Full Text] [Related]
6. Steroid hormone receptor expression in male breast cancer.
Murphy CE; Carder PJ; Lansdown MR; Speirs V
Eur J Surg Oncol; 2006 Feb; 32(1):44-7. PubMed ID: 16260112
[TBL] [Abstract][Full Text] [Related]
7. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of CD34, alpha-SMA and h-caldesmon expression in the stroma of gynaecomastia and male breast carcinoma.
Kalekou H; Kostopoulos I; Milias S; Papadimitriou CS
Histopathology; 2005 Jul; 47(1):74-81. PubMed ID: 15982326
[TBL] [Abstract][Full Text] [Related]
9. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
Gonzalez LO; Corte MD; Junquera S; Bongera M; Rodriguez JC; Vizoso FJ
Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076
[TBL] [Abstract][Full Text] [Related]
10. Steroid hormone receptors in male breast diseases.
Pacheco MM; Oshima CF; Lopes MP; Widman A; Franco EL; Brentani MM
Anticancer Res; 1986; 6(5):1013-7. PubMed ID: 3026231
[TBL] [Abstract][Full Text] [Related]
11. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of apolipoprotein D in male breast cancer and gynaecomastia.
Serra Díaz C; Vizoso F; Lamelas ML; Rodríguez JC; González LO; Baltasar A; Medrano J
Br J Surg; 1999 Sep; 86(9):1190-7. PubMed ID: 10504376
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen may serve as a pathological predictor in breast cancer.
Nariţa D; Anghel A; Motoc M
Rom J Morphol Embryol; 2008; 49(2):173-80. PubMed ID: 18516323
[TBL] [Abstract][Full Text] [Related]
14. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study.
Sasano H; Kimura M; Shizawa S; Kimura N; Nagura H
J Clin Endocrinol Metab; 1996 Aug; 81(8):3063-7. PubMed ID: 8768875
[TBL] [Abstract][Full Text] [Related]
15. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray.
Dakin Haché K; Gray S; Barnes PJ; Dewar R; Younis T; Rayson D
Breast Cancer Res Treat; 2007 Oct; 105(2):169-75. PubMed ID: 17268818
[TBL] [Abstract][Full Text] [Related]
17. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia.
Burgess HE; Shousha S
J Pathol; 1993 May; 170(1):37-43. PubMed ID: 8326458
[TBL] [Abstract][Full Text] [Related]
19. Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
Webster LR; Lee SF; Ringland C; Morey AL; Hanby AM; Morgan G; Byth K; Mote PA; Provan PJ; Ellis IO; Green AR; Lamoury G; Ravdin P; Clarke CL; Ward RL; Balleine RL; Hawkins NJ
Clin Cancer Res; 2008 Oct; 14(20):6625-33. PubMed ID: 18927304
[TBL] [Abstract][Full Text] [Related]
20. Expression of prolactin and its receptor in human breast carcinoma.
Reynolds C; Montone KT; Powell CM; Tomaszewski JE; Clevenger CV
Endocrinology; 1997 Dec; 138(12):5555-60. PubMed ID: 9389544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]